Have you submitted any patent applications yet? Also, given your academic affiliation, what interest does Berkeley have in the IP?

Hi Laurel. We will be submitting patents in January 2021! Berkeley has no ownership of IP because I developed this technology after any formal employment at the university. My affiliation is as an alumnus. Thanks for asking! Best, Dave

Hello Dave, Do you plan to have your algorithm integrated with a DICOM reader or would this be a stand alone suite of tools for analysis by a doctor? Does this require any FDA approvals for use? How do you plan to roll out the software, one time purchase or would it be a subsc...

Hi Benjamin,Re: DICOM: We will be a stand-alone analysis where health providers can upload patient data into an online portal for us to download. Re: FDA approval: In the long run, yes, but as with any new diagnostic technology we just need to make clear to our customers, through the standard disclaimers, that our technology is not FDA approved. We will seek FDA approval towards the end of 2021. Re: software rollout: We will have a subscription model. We will receive our 250 initial...

Hi there! Do you plan to further extend the list of illnesses the algorithm can scan after your launch your current version?

Hi, Evgeny. Yes, we plan to work on predicting bipolar disorder, schizophrenia, Alzheimer's, Autism, and ADHD. In the next year or two, the primary focus will be on bipolar disorder, Schizophrenia, and Alzheimer's. Best, Dave

You include free 'risk analyses' in your perks. What are the details related to completing an analyses? Where do you go, does it including paying for an MRI or EEG, etc.? Thank you.

MRI’s can be performed at any outpatient imaging center or hospital. Once you have the MRI result, we can send you or your clinic a website to upload the MRI. We then download your MRI from this portal and perform an analysis. The resulting risk score report and relevant resources and information will be sent to you as a pamphlet. However, since we have not received FDA approval in the USA, we cannot send anyone in the USA an analysis. We can only send our analysis to people who live in Latin...

Hi, have you filed the first patent?

Hi T Baillie, Yes, we have filed for a provisional patent.

BrainScanology

A novel shape analysis software revolutionizing STEM discoveries and STEM education

Pitch Video

Investor Panel

brainscanology.com

San Francisco, CA

Technology Female Founder B2B Healthcare Biotech

Investor Panel

Fares and Shu interviewed BrainScanology on February 23, 2021. Play Video

Fares Ksebati

CEO of MySwimPro

Shu Li

CEO and co-founder of Petri-Bio

Strengths

says, "I really like the scientific expertise that created the algorithm. there is a clear value proposition to being more efficient and cheaper compared to the status quo. early disease detection is huge!"

says, "Mission-driven founders with extensive experience in the related fields. Their technology seems to have competitive advantages over existing solutions"

Advice

says, "I'd like to see how quickly this can scale into operational use. These industries are usually slow and bureaucratic. Speed is critical! Best of luck!"

says, "Look forward to seeing progress on business partnership development and regulation process."

What Investors Say

Controller, H.A. Bowen Electric

LEAD INVESTOR

Invested $2,500 this round

Dave Nguyen's drive to create, discover and positively affect his environment serve to define who he is as an individual. He has always been passionate about helping and serving people in need. As founder of BrainScanology, I have zero doubt in my mind that he will leverage all of these great qualities into profound success within the neuroscience field. His research experience merged with his algorithm development will push the envelope of what we thought was possible within the area of neuro diagnosis. The future results will be truly groundbreaking.

What People Say

BrainScanology

Quick facts

Team profiles

Featured investor profiles

$241,265

Investor Panel

What Investors Say